Literature DB >> 6949608

Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.

C R Pinkerton, S G Welshman, J M Bridges.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6949608      PMCID: PMC2010896          DOI: 10.1038/bjc.1982.47

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction.

Authors:  I D Goldman
Journal:  Cancer Treat Rep       Date:  1977-07

2.  Acute lymphocytic leukemia in childhood.

Authors:  J Simone
Journal:  Semin Hematol       Date:  1974-01       Impact factor: 3.851

3.  Pharmacokinetics of methotrexate.

Authors:  D H Huffman; S H Wan; D L Azarnoff; B Hogstraten
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  Sites of action of amethopterin: intrinsic and acquired drug resistance.

Authors:  K R Harrap; B T Hill; M E Furness; L I Hart
Journal:  Ann N Y Acad Sci       Date:  1971-11-30       Impact factor: 5.691

5.  Continuous infusion of methotrexate in children with acute leukemia.

Authors:  I Djerassi; S Farber; E Abir; W Neikirk
Journal:  Cancer       Date:  1967-02       Impact factor: 6.860

6.  Comparison of serum concentrations of methotrexate after various routes of administration.

Authors:  M Freeman-Narrod; B J Gerstley; P F Engstrom; R S Bornstein
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

7.  Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis.

Authors:  W C Noble; P M White; H Baker
Journal:  J Invest Dermatol       Date:  1975-02       Impact factor: 8.551

8.  Some observations on the human pharmacology of methotrexate.

Authors:  A H Calvert; P K Bondy; K R Harrap
Journal:  Cancer Treat Rep       Date:  1977-12

9.  Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.

Authors:  P J Kearney; P A Light; A Preece; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

10.  Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia.

Authors:  C R Pinkerton; S G Welshman; S I Dempsey; J M Bridges; J F Glasgow
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

View more
  2 in total

1.  Serum profiles and safety of intermediate-dose (500-1,000 mg) methotrexate following IV and IM administration.

Authors:  B M Colls; R A Robson; B A Robinson; G W Tisch
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

2.  Modification of oral methotrexate absorption in children with leukemia.

Authors:  M J Mahony; M S Murphy; J Wadsworth; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.